Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
about
Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosisThe association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.Association between murine double minute 2 T309G polymorphism and risk of liver cancer.TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.Combined effects of genetic variants of the PTEN, AKT1, MDM2 and p53 genes on the risk of nasopharyngeal carcinoma.MDM2 SNP309 variation confers the susceptibility to hepatocellular cancer: a meta-analysis based on 4271 subjectsGenome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in GuangxiThe association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.ASSOCIATION BETWEEN MURINE DOUBLE MINUTE 2 - T309G polymorphism and recurrence of hepatocellular carcinoma after surgical treatment.Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma.Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing mice.MDM2 SNP309T>G polymorphism and hepatocellular carcinoma risk: a meta-analysis.MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?MDM2 SNP309 is an ethnicity-dependent risk factor for digestive tract cancers.
P2860
Q33739952-8084AED5-6B23-40DC-8C14-4B0789B34680Q33833557-9C4EC801-CCA0-483A-98F3-54CED71AC7E8Q34380438-71082FBB-2B22-416A-BB0D-ABF748DAEEB6Q34433411-9A6C0D24-CB5B-4886-818E-139706837536Q35077721-7123E558-979B-4A88-9C6E-08B7318D8CA2Q35121522-896773F4-EB60-46E4-AA68-1BD28A5CB1B7Q35791375-FF6D57AE-DFE5-4911-9EE3-CEDE4F053E2BQ36879598-6D8DFE64-F46A-45B4-8CB6-74775A253DEAQ38402258-5995A9DE-D291-4045-BA02-630A20AC738BQ40933867-7DBB1D1D-E3BA-4482-82F7-408C3AEB31C8Q40947646-E865B518-7EED-4BB3-B32B-2E2A18C8C3CDQ45228677-F8E29C5C-8FA6-430E-8BDD-AA0389ECFE99Q46327354-BF7CD611-1D24-421A-86DD-34B393001A75Q46761401-A16FDCE4-3E4C-4C5C-9729-F2885FB503D5Q52340395-C63EEB80-84A0-4A8D-BDB6-7FB566ABCF17Q54439530-C1D62E20-8E87-4F70-8949-6D80520F285E
P2860
Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combined effects of p53 and MD ...... ated hepatocellular carcinoma.
@en
type
label
Combined effects of p53 and MD ...... ated hepatocellular carcinoma.
@en
prefLabel
Combined effects of p53 and MD ...... ated hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Combined effects of p53 and MD ...... lated hepatocellular carcinoma
@en
P2093
Qiang Deng
Weiping Zhou
Wenming Cong
P2860
P2888
P356
10.1007/S13238-012-2067-9
P50
P577
2012-12-22T00:00:00Z